Value through Innovation27 July 2016

Clinical Study Results

  • BUSCOPAN ® - Colic
    Clinical Study Number 202.832
    Study Indication Colic
    Product BUSCOPAN ®
    Generic Name Hyoscine butylbromide
    Lab Code
    Clinical Phase II
    Study Title

    A double-blind, placebo-controlled, randomized, parallel group study of the efficacy and safety of oral doses of 20 mg hyoscine butylbromide when used on-demand up to 7 episodes over a period of 6 weeks for the treatment of occasional episodes of self reported abdominal pain, cramping, and discomfort associated with cramping in an OTC like study population

    Study Document Trial synopsis 202.832_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.